BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9589057)

  • 21. RET protooncogene mutations in patients with apparently sporadic medullary thyroid carcinoma.
    Huang CN; Wu SL; Chang TC; Huang SH; Chang TJ
    J Formos Med Assoc; 1998 Aug; 97(8):541-6. PubMed ID: 9747064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.
    Papi G; Corrado S; Pomponi MG; Carapezzi C; Cesinaro A; LiVolsi VA
    Endocr Pathol; 2003; 14(3):269-76. PubMed ID: 14586073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
    Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
    J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ret proto-oncogene mutation found in the Czech population and its predictive value for offspring of patients with medullary carcinoma of the thyroid gland].
    Mazura I; Vcelák J; Bendlová B; Neradilová M; Nĕmec J; Stolba P
    Vnitr Lek; 1996 Nov; 42(11):751-6. PubMed ID: 9012117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.
    Lombardo F; Baudin E; Chiefari E; Arturi F; Bardet S; Caillou B; Conte C; Dallapiccola B; Giuffrida D; Bidart JM; Schlumberger M; Filetti S
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1674-80. PubMed ID: 11932300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature.
    Kebebew E; Tresler PA; Siperstein AE; Duh QY; Clark OH
    Thyroid; 1999 Feb; 9(2):127-31. PubMed ID: 10090311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current management of medullary thyroid cancer.
    Sippel RS; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ; Mulligan LM; Eng C
    Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Consequences of clinical genetic analysis of RET proto-oncogene].
    Włoch J; Wygoda Z; Wiench M; Gubała E; Kula D; Oczko M; Lange D; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():406-14. PubMed ID: 12182057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
    Rone JK; Lane AG; Grinkemeyer MD
    Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and genetic screening of an extended family with MEN2A.
    Algün E; Abaci N; Kösem M; Kotan C; Köseoğlu B; Boztepe H; Sekeroğlu R; Aslan H; Topal C; Ayakta H; Uygan I; Alagöl F; Erginel-Unaltuna N; Aksoy H
    J Endocrinol Invest; 2002; 25(7):603-8. PubMed ID: 12150334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy.
    Dang GT; Cote GJ; Schultz PN; Khorana S; Decker RA; Gagel RF
    Mol Cell Probes; 1999 Feb; 13(1):77-9. PubMed ID: 10024437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidental detection of familial medullary thyroid carcinoma by calcitonin screening for nodular thyroid disease.
    Mayr B; Brabant G; von zur Mühlen A
    Eur J Endocrinol; 1999 Sep; 141(3):286-9. PubMed ID: 10474127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
    Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
    Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of metastatic medullary thyroid carcinoma: early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens.
    Russo D; Arturi F; Chiefari E; Meringolo D; Bianchi D; Bellanova B; Filetti S
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3378-82. PubMed ID: 9329372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Video assisted prophylactic thyroidectomy and central compartment nodes clearance in two RET gene mutation adult carriers.
    Miccoli P; Elisei R; Berti P; Materazzi G; Agate L; Castagna MG; Cosci B; Faviana P; Ugolini C; Pinchera A
    J Endocrinol Invest; 2004 Jun; 27(6):557-61. PubMed ID: 15717653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.